31.05.2016 16:56:00

Pfizer Inc. -- Moody's assigns A1 to Pfizer's new notes; negative outlook

New York, May 31, 2016 -- Moody's Investors Service assigned a rating of A1 to the new senior unsecured note offering of Pfizer Inc. ("Pfizer"). There are no changes to Pfizer's existing ratings and the rating outlook remains negative. Uses of the proceeds may include general corporate purposes, including repaying a portion of outstanding commercial paper borrowings.

Vollständigen Artikel bei Moodys lesen